NewsBusiness Tilray reports mixed FQ1 with top-line growth of 13% and 38% reduction in net loss October 10, 2024 0 Facebook Twitter Pinterest WhatsApp ReddIt Earnings Snapshot: Tilray Brands reports mixed FQ1 with 13% growth in revenue and 38% reduction in net loss Safety Shot reports Q2 resultsDateAugust 16, 2024In relation toBusinessNervGen Pharma reports Q2 results (OTCMKTS:NGENF)DateAugust 23, 2024In relation toBusinessJack Nathan Medical reports Q1 resultsDateJune 21, 2024In relation toBusiness